Objective. This study aimed to characterize premature mortality among people diagnosed with HIV infection from 2000 to 2009 in Florida, by sex and race/ ethnicity, to estimate differences in premature mortality that could be prevented by linkage to HIV care and treatment.
Minority groups in the United States are disproportionately affected by human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS). In 2009, the estimated annual HIV incidence rate was 7.7 times higher for non-Hispanic black (NHB) people and 2.6 times higher for Hispanic people than for non-Hispanic white (NHW) people (69.9, 26.4, and 9.1 per 100,000 population, respectively). 1 These racial/ethnic disparities persist in HIV mortality rates. In 2010, the age-adjusted HIV mortality rate among NHB people was 7.2 times greater for men (16.5 vs. 2.3 per 100,000 population) and 15.0 times greater for women (7.5 vs. 0.5 per 100,000 population) than among NHW people. 2 In the era of antiretroviral therapy (ART), the life span among people living with HIV who are appropriately treated is approaching that of underlying populations. 3, 4 As people living with HIV live longer, they are more likely to die from non-HIV causes such as heart disease, liver disease, and cancer. [5] [6] [7] Numerous studies have documented a declining proportion of deaths due to AIDS, particularly for those in care. [8] [9] [10] However, the benefits of ART have not been fully realized for the majority of people living with HIV. To benefit from these treatment advances, individuals must be diagnosed early in the course of their illness, be linked to care, be offered treatment, and adhere to treatment. Nationally, people are being lost at each step of this continuum. It is estimated that in 2009, 66% of people diagnosed with HIV were linked to care, 37% were retained in care, 33% were prescribed ART, and 25% had a suppressed viral load. Relative to NHW people, NHB people (and, to a lesser extent, Hispanic people) had lower percentages at each step of the care continuum. In 2009, an estimated 79% of NHB, 74% of Hispanic, and 70% of NHW people with HIV infection had no viral load suppression. 11 HIV is a burden for communities because it tends to cause death at younger ages than more common causes of death (e.g., cancer and heart disease). Comparing the impact of HIV using mortality rates alone does not capture the impact of premature mortality. However, years of potential life lost (YPLL), which measures premature mortality, tallies the number of years a person would have been expected to live had he/she not died early. 12 The objective of this study was to characterize premature mortality among people diagnosed with HIV from 2000 to 2009 in Florida, by sex and racial/ ethnic group, to estimate differences in premature mortality that could be prevented by linkage to HIV care and treatment. Florida residents reported  during 2000-2009 with HIV that met the Centers for  Disease Control and Prevention surveillance case definition 13, 14 were obtained from the Florida Department of Health (DOH) Enhanced HIV/AIDS Reporting System (eHARS). Individual-level variables included month and year of HIV and AIDS diagnosis (if applicable); age at HIV diagnosis; age at death (if applicable); sex; race/ethnicity; HIV transmission mode; and number of months between HIV diagnosis and death, or December 2011, whichever came first. Cases with concurrent AIDS were excluded to characterize differences in premature mortality due to care and treatment as opposed to late diagnosis. Concurrent AIDS was defined as an AIDS diagnosis within three months of HIV diagnosis because there can be more than a month delay from time of test to follow-up evaluation, and the Centers for Disease Control and Prevention recommends that people start HIV care within three months of diagnosis. 15 Deaths and their underlying causes through December 2011 were ascertained by matching eHARS records with Florida DOH Vital Records, the Social Security Administration's Death Master File, and the National Death Index. Underlying causes of death during the study period were coded with the International Classification of Diseases, Tenth Revision (ICD-10) codes. 16 Causes were categorized based on work from the National Center for Health Statistics 17 into the following groups: (1) deaths due to HIV/AIDS (B20-B24);
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(2) homicide (U01-U02, X85-Y09, and Y87.1); (3) suicide (U03, X60-X84, and Y87.0); (4) unintentional injuries (V01-X59 and Y85-Y86); (5) psychoactive drug use (F10-F19); (6) other infections (A01-B19.9, B25-B99, and J09-J22); (7) heart disease (I00-09, Ill, I13, and I20-I51); (8) cerebrovascular disease (I60-I69); (9) cancer (C00-C97); (10) chronic lower respiratory diseases (J40-J47); (11) diabetes (E10-E14); (12) chronic liver disease (K70 and K73-K74); (13) other medical (all other codes); and (14) unknown (no code) and external causes without context of intent (S09-S09.9 and T01-T71). To estimate the extent to which premature mortality could have been prevented by early HIV diagnosis and linkage to care, causes-ofdeath groups were collapsed into the following four categories: deaths due to HIV/AIDS (group 1), deaths due to external causes (groups 2-5), non-HIV/AIDS medical (groups 6-13), and unknown (group 14). This grouping was based on the premise that the deaths due to HIV/AIDS were potentially preventable by HIV care Premature HIV Mortality  507 Public Health Reports / September-October 2015 / Volume 130 and treatment. The causes of death were stratified by race/ethnicity and sex and compared.
ZIP Code-level poverty data from the 2000 U.S. Census were obtained from the U.S. Census Bureau 18 and linked using the ZIP Code Tabulation Area™. 19 The U.S. Census Bureau reports data by ZIP Code Tabulation Area, which approximates a ZIP Code and is built by aggregating U.S. Census Bureau blocks based on the ZIP Code of addresses in these blocks. Records of diagnosed HIV cases with missing or nonexisting ZIP Codes were excluded from the analysis. Neighborhoodlevel poverty was measured using the five-year estimate of the percentage of the population living below the federal poverty level in each ZIP Code Tabulation Area. Poverty was used because it was associated with survival in an earlier study of this group. 20 YPLL, defined as the expected number of years of life remaining for a given age and sex, was obtained from the sex-specific U.S. period life tables for the year the person died. [21] [22] [23] [24] [25] We used this method, employed in several other studies, 26-29 rather than subtracting age at time of death from a specific age cutoff such as 75 years because women have longer life expectancies than men due in part to biological differences, 30 and a uniform cutoff age ignores this fact. Additionally, most people living with HIV/AIDS in the United States die as adults, and age 75 is close to the average life expectancy (i.e., 78.5 years at birth in 2009). Using a 75-year cutoff would lead to an undercounting of YPLL for older individuals. For example, a 55-year-old man had a life expectancy of 80 years in 2009. 21 If he had died at age 55, he would have a YPLL of 20 using the age 75 cutoff method and 25 using his life expectancy.
Years of observation were calculated by dividing the number of months between dates of diagnosis and death or December 2011 (if the person did not die) by 12. Observation time was considered because our cohort spanned 10 years. If a person was followed for only one year rather than 10 years, that person would have less opportunity to die prematurely. The crude YPLL rate due to all causes of death per 1,000 person-years for each sex and racial/ethnic group was calculated as follows:
where: ypll is years of potential life lost based on allcause mortality py is person-years of observation i indexes the individual in demographic group who died j indexes the individual in demographic group (alive or dead)
The crude cause-specific YPLL per 1,000 person-years for each sex and racial/ethnic group was calculated similarly except that only deaths due to a given cause were considered.
To account for different distributions of age at diagnosis by racial/ethnic group, age-standardized YPLL per 1,000 person-year rates were calculated by direct standardization using the 2000 U.S. population. 31 Age-specific YPLL per 1,000 person-year rates were calculated for each sex and racial/ethnic group. These rates were multiplied by the number of people in each age group for the 2000 U.S. population. Results for each age group were summed and divided by the total number of people to obtain the age-standardized YPLL. The 95% confidence intervals (CIs) for the age-adjusted YPLL rates were calculated based on the gamma distribution, including an inflation factor Phi to account for overdispersion. [32] [33] [34] Racial/ethnic disparities in YPLL due to HIV/AIDS were determined using the individual's number of YPLL as the dependent variable and controlling for age at diagnosis, country of birth, length of observation, year of diagnosis, mode of HIV transmission, and neighborhood poverty level. Multilevel linear regression models were fitted using the SAS ® GLIMMIX procedure. 35 A random intercept was used to account for Zip Code Tabulation Area clustering. We conducted all analyses using SAS ® version 9.3. 36 9, 70.8) . aYPLL due to other medical causes was similar for males and females ( Table 2) .
RESULTS
Among females, NHB women had a higher aYPLL due to HIV/AIDS than NHW and Hispanic women (388.2, 294.3, and 295.0, respectively). NHB females had a significantly higher aYPLL due to all causes and other medical causes than Hispanic women but not NHW women. NHW females had a significantly higher aYPLL due to external causes than NHB and Hispanic females (86.8, 35.7, and 48.4, respectively) ( Table 2) .
Among males, NHB people had a significantly higher aYPLL due to all causes, HIV/AIDS, and other medical causes than NHW and Hispanic people. NHB males had a significantly lower aYPLL due to external causes than NHW males (52.0 vs. 79.0). There were no significant differences between Hispanic and NHW males for aYPLL due to all causes or any specific cause ( Table 2) .
The proportion of aYPLL due to HIV per 1,000 person-years was higher among NHB and Hispanic females (52.8% and 55.0%, respectively) than among NHB and Hispanic males (49.7% and 46.8%, respectively) and also higher than among NHW females (45.1%) and NHW males (45.0%) (Figure) .
In the multilevel model fitted with YPLL due to HIV/AIDS as the dependent variable controlling for all covariates except poverty, NHB race was more strongly associated with increased YPLL than NHW race for women (estimate 5 0.517, standard error [SE] 5 0.248, p50.038) and men (estimate 5 0.752, SE50.150, p,0.001). This finding indicates that for every one YPLL among NHW women and men, there was 1.52 YPLL among NHB women and 1.75 YPLL among NHB men. However, when neighborhood poverty was added to the model, NHB was no longer significant for females (estimate 5 0.266, SE50.255, p50.297), and the estimate became smaller for males (estimate 5 0.606, SE50.154, p,0.001). In both sex models, the estimates for the highest quartile of poverty were larger than those for race/ethnicity and significant (males: estimate 5 1.483, SE50.325, p,0.001; females: estimate 5 1.927, SE50.537, p,0.001). There was no significant difference between Hispanic and NHW people for either males or females in any of the models (data not shown).
DISCUSSION
In estimating premature mortality due to HIV/AIDS by sex and race/ethnicity, we came up with two main findings. First, we found that females had greater aYPLL due to all causes than males and that NHB and Hispanic females had a higher proportion of aYPLL due to HIV/ AIDS than did NHB and Hispanic males. Second, we found that among women and men, NHB people had a higher aYPLL due to HIV/AIDS than NHW people. This difference persisted for men and women after controlling for individual-level factors. After controlling for poverty, however, the differences between NHB and NHW people disappeared for females and decreased for males, suggesting that factors associated with poverty may be influencing the disparities in premature mortality. As secondary findings, neighborhood-level poverty was strongly associated with aYPLL and influenced the association between race and aYPLL. Moreover, we found that NHW people had a higher aYPLL than NHB people due to external causes mostly due to unintentional injuries.
Females had a greater aYPLL due to all causes, partially due to their longer life expectancy, making the individual cost of HIV greater for females than for males. The higher aYPLL due to HIV among females compared with males was mostly due to higher aYPLL among NHB and Hispanic females relative to NHB and Hispanic males. Additionally, for NHB and Hispanic people, females had a greater proportion of YPLL due to HIV than males. A study using surveillance data from 25 U.S. states also found that in 2005, the average number of YPLL due to all causes, calculated using life tables, was higher for females (22.7) than for males (19.1). 28 Available evidence indicates that ART is not more effective in males than in females in terms of virologic, immunologic, or clinical outcomes. [37] [38] [39] Yet, several studies have found that females in the United States are less likely to be prescribed ART than males. [40] [41] [42] Several studies have also indicated that women are less adherent to ART than men. 39 Estimates indicate that the percentage of women in the United States with a suppressed viral load is similar to men, despite women being more likely to be diagnosed. 11 There were no variables in the surveillance dataset that we could use to determine linkage to care or adherence to treatment in our Florida population. Further studies need to focus on the accessibility of care and assess fully the levels of adherence to treatment in Florida.
We also found that NHB people overall had greater premature mortality than NHW and Hispanic people. NHB people also had a larger proportion of premature mortality due to HIV than NHW people. Our results are consistent with results from a study of surveillance data from 25 U.S. states that found that at ages 20, 40, and 60 years, NHB people had more premature mortality than NHW people. 28 The association between NHB race/ethnicity and YPLL due to HIV did not persist for NHB females after controlling for neighborhood poverty, and the association became weaker among men. This finding suggests that factors related to neighborhood poverty level contribute to this disparity. These factors could be structural, such as access to care, social support, homelessness, transportation problems, or unmet child care needs. 43, 44 Additionally, people living in poorer neighborhoods are themselves more likely to be impoverished, and lower individual socioeconomic status is associated with reduced access to information, resources, power, and useful social networks, resulting in health inequalities. 45 In terms of aYPLL, we found little evidence that Hispanic people with HIV were disadvantaged relative to NHW people. In fact, Hispanic females had a lower aYPLL due to all causes than their NHW counterparts. There were no other significant differences between the two groups. This finding contrasts the results of a study of surveillance data from 25 U.S. states, which found that in 2005, NHW people had fewer YPLL than Hispanic people at 20, 40, and 60 years of age. 28 Mexico (compared with 19.4% who were born in the United States) and 16.6% were born in Cuba (compared with 2.8% who were born in the United States); 46 and, in the United States, more Mexican Americans (24.9%) than Cuban Americans (16.2%) reported living below the federal poverty level from 2007 to 2011. 47 
Limitations
This study was subject to several limitations, which should be noted. First, not all premature mortality due to HIV is preventable by care and treatment. Much premature mortality among people living with HIV/AIDS is related to individual risk behaviors. We could control for these individual risk behaviors in only a limited way in the multivariate analysis using the variable HIV mode of transmission. Second, all decedents were known to have HIV infection, but some deaths may have been misclassified as being due to certain opportunistic infections or cancers instead of HIV. Additionally, there is evidence that HIV infection is associated with an increased risk of non-AIDSdefining medical conditions, including renal, liver, neoplastic, and cardiovascular diseases. 48 Therefore, our estimate of premature mortality due to HIV was likely conservative.
Third, premature mortality due to HIV is affected by competing causes of death, such that one group's HIV mortality could be lower than another's if a competing cause such as cancer or unintentional injury was more common; however, we were not able to control for competing causes in our analysis. Fourth, the cause of death was missing for 4.8% of the group, and this proportion was higher for Hispanic people. Missing causes occurred when deaths obtained from the Social Security Death Index had no match in the National Death Index. Fifth, our sample was from Florida only, which may limit the generalizability of the results. Underlying barriers to treatment and care may vary by state. Florida has a particularly high burden of HIV. In 2012, Florida had the fourth highest estimated rate of people living with diagnosed HIV infection (585.8 per 100,000 population) after the District of Columbia, New York, and Maryland. 49 
CONCLUSION
Our study identified several disparities by sex and race/ethnicity in premature mortality from HIV. These disparities could potentially be addressed by expanding care and treatment efforts, particularly for women and NHB people.
